(Q37658761)

21 August 2017

1 reference

title

Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer (English)

1 reference

21 August 2017

author name string

Elfriede Bollschweiler

series ordinal

1

1 reference

21 August 2017

Arnulf H Hölscher

series ordinal

2

1 reference

21 August 2017

Ralf Metzger

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

25-35

1 reference

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Neoadjuvant therapy for oesophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Grading of tumor regression in non-small cell lung cancer : morphology and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation].

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Esophageal carcinoma with doubtful extirpability. Value of preoperative chemotherapy plus radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the esophagus: results of a study of 56 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

Survival After Neoadjuvant Therapy Compared with Surgery Alone for Resectable Esophageal Cancer in a Population-based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.133

21 January 2018

Identifiers

DOI

10.2217/FON.09.133

1 reference

21 August 2017

1 reference